Renal Biomarkers Market to Grow with a CAGR of 7.25% through 2028
Rising prevalence of kidney diseases and increased drug
development and clinical trials are factors driving the Global Renal Biomarkers
Market in the forecast period 2024-2028
According to TechSci Research report, “Renal
Biomarkers Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Renal Biomarkers Market
stood at USD 1.31 billion in 2022 and is anticipated to grow with a CAGR of 7.25%
in the forecast period, 2024-2028. The global renal
biomarkers market has been steadily growing in recent years, driven by various
factors that highlight the increasing importance of renal function assessment
in healthcare. Renal biomarkers play a crucial role in the diagnosis,
prognosis, and management of kidney-related diseases and disorders. One of the
primary drivers of the global renal biomarkers market is the growing prevalence
of kidney diseases worldwide. Conditions such as chronic kidney disease (CKD),
acute kidney injury (AKI), and diabetic nephropathy have become increasingly
common due to factors like aging populations, sedentary lifestyles, and the
rising incidence of diabetes and hypertension. As the burden of kidney diseases
continues to rise, the demand for effective biomarker-based diagnostic and
monitoring tools has also increased. Advancements in diagnostic technologies have significantly
contributed to the growth of the renal biomarkers market. The development of
sensitive and specific assays for renal biomarkers has improved the accuracy of
kidney disease diagnosis and monitoring. Innovative techniques, such as mass
spectrometry and immunoassays, have enabled healthcare professionals to detect
renal biomarkers in blood and urine samples with high precision. These
technological advances have made early detection and intervention for kidney
diseases possible, driving market growth.
The healthcare industry has witnessed a
shift towards personalized medicine, wherein treatments are tailored to
individual patients based on their genetic makeup and specific health
conditions. Renal biomarkers play a pivotal role in personalized medicine,
helping physicians identify the most suitable treatment plans for patients with
kidney diseases. This approach not only enhances patient outcomes but also
drives demand for renal biomarker testing. Rising healthcare expenditure
across the globe has provided a substantial boost to the renal biomarkers
market. As governments and healthcare organizations allocate more resources to
address the growing burden of kidney diseases, there is a greater emphasis on
early diagnosis and effective disease management. This has led to increased
investments in diagnostic tests and technologies, including renal biomarkers,
which are critical for efficient patient care. The Global Renal Biomarkers Market
is segmented into product type, technique, end user and company. Based on end
user, the Hospitals
& Clinics segment has emerged as the predominant market leader. Hospitals and
clinics are undeniably central players in the global renal biomarkers market.
Their pivotal role in patient care, access to advanced diagnostic facilities,
and commitment to research and development ensure that they remain at the
forefront of renal biomarker utilization. As the burden of kidney-related
diseases continues to grow, these healthcare institutions will play a crucial
role in early detection, diagnosis, and management, ultimately improving
patient outcomes and the overall state of global healthcare.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Renal Biomarkers Market.”
Based on region, North America segment is expected to
grow during the forecast period. North America's dominant position
in the global renal biomarkers market is a testament to its commitment to
healthcare research, innovation, and clinical adoption. As the region continues
to lead in the development and application of renal biomarkers, the future
holds promise for improved diagnostics and treatments for kidney-related
diseases, benefiting patients around the world. The synergy between research
institutions, industry players, and regulatory bodies in North America serves
as a model for progress in the healthcare industry, setting high standards for
the rest of the world to follow.
The Asia Pacific region is experiencing rapid market
growth. Healthcare providers in Asia Pacific are quick to adopt innovative
diagnostic tools and treatments. The awareness of the importance of early
detection and management of kidney-related diseases has led to a high demand
for renal biomarkers in clinical settings.
Major companies operating in Global Renal
Biomarkers Market are:
- Abbott Laboratories
- Beckman Coulter Inc. (Danaher
Corporation)
- bioMerieux SA
- BioPorto A/S
- Bio-Rad Laboratories Inc.
- Enzo Biochem Inc.
- F. Hoffmann-La Roche AG
- PerkinElmer Inc.
- Randox Laboratories Ltd.
- Siemens AG
- Thermo Fisher Scientific Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global renal biomarkers market is experiencing
robust growth driven by a combination of factors, including the rising
prevalence of kidney diseases, advancements in diagnostic technologies, the
shift towards personalized medicine, increased healthcare expenditure, drug
development needs, and growing public awareness. As the healthcare industry
continues to evolve and prioritize kidney health, the renal biomarkers market
is expected to expand further, providing improved diagnostic and monitoring
solutions for kidney-related conditions.,” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Renal Biomarkers Market By Product Type (Functional
Biomarker, Serum Creatinine, Serum Cystatin C, Urine Albumin, Up-regulated
Protein, Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury
Molecule-1, INTERLEUKIN-18, Others), By Technique (Enzyme-linked Immunosorbent
Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA),
Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid
Chromatography Mass Spectrometry (LC-MS)), By End user (Hospitals
& Clinics, Diagnostic Laboratory, Others), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Renal Biomarkers Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Renal Biomarkers Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com